TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Asset Utilization Ratio (2023)

TFA Therapeutics (RAJAF) posted Asset Utilization Ratio of 0.18 for Q4 2023.

Analysis

TFA Therapeutics (RAJAF) Asset Utilization Ratio (2023) Analysis & Trends

TFA Therapeutics has reported Asset Utilization Ratio for 1 years, with the latest figure at 0.18 in Q4 2023.

  • On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.18 in Q4 2023; TTM through Dec 2023 was 0.18, a N/A change from a year earlier, with the FY2025 full-year figure at 0.27, down 14.63% from the prior year.
  • Asset Utilization Ratio was 0.18 for Q4 2023 at TFA Therapeutics.
  • The five-year high for Asset Utilization Ratio was 0.18 in Q4 2023, with the low at 0.18 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Colgate Palmolive 70.19 Bn 68.82 Bn 3.30 Bn 1.26
2 Kenvue 34.67 Bn 33.56 Bn 2.30 Bn 0.58
3 Kimberly Clark 33.45 Bn 32.49 Bn 1.60 Bn 0.93
4 Bath & Body Works 3.95 Bn 3.15 Bn 692.00 Mn 1.44
5 Prestige Consumer Healthcare 2.38 Bn 2.31 Bn - -
6 Perrigo 2.02 Bn 1.62 Bn 313.90 Mn 0.53
7 Herbalife 1.27 Bn 894.99 Mn 1.03 Bn 1.81
8 Edgewell Personal Care 1.26 Bn 863.27 Mn 242.50 Mn 0.63
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 623.99 Mn 518.09 Mn 40.36 Mn 1.57
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.18